Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence.
about
Hepatitis C - Assessment to Treatment Trial (HepCATT) in primary care: study protocol for a cluster randomised controlled trial.Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.Estimating high-risk cannabis and opiate use in Ankara, Istanbul and Izmir.Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
P2860
Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Problem drug use prevalence es ...... the role of external evidence.
@en
Problem drug use prevalence es ...... the role of external evidence.
@nl
type
label
Problem drug use prevalence es ...... the role of external evidence.
@en
Problem drug use prevalence es ...... the role of external evidence.
@nl
prefLabel
Problem drug use prevalence es ...... the role of external evidence.
@en
Problem drug use prevalence es ...... the role of external evidence.
@nl
P2093
P2860
P50
P356
P1433
P1476
Problem drug use prevalence es ...... the role of external evidence.
@en
P2093
Barbara Coleman
Wyn Davies
P2860
P304
P356
10.1111/ADD.13222
P407
P577
2015-10-24T00:00:00Z